Systematic review and meta-analysis: CAR-T vs bispecific antibody as third or later-line therapy for follicular lymphoma. - Ng LCK; Lee XH; Tan YC; Wong KL; Chow JCY; Ling VWT; Thong EWS; Chan EHL; Chan WL; Samuel M; Poon MLM (Blood cancer journal, 2025)